Fluorescence Lifetime Imaging for Quantification of Targeted Drug Delivery in Varying Tumor Microenvironments
A. Verma, V. Pandey, C. Sherry, C. James, K. Matteson, J. T. Smith, A. Rudkouskaya, X. Intes, M. Barroso
This study uses fluorescence lifetime imaging to quantify TZM-HER2 binding and distribution in tumors with varying microenvironments, showing differences in drug delivery efficacy between cancer types.
bioRxiv · Jan 12, 2024Cancer Biology